BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Beach

  VivaLNK Launches IoT-Enabled Medical Wearable Sensor Platform for Continuous Patient Monitoring

  Vitalic Medical partners with VivaLNK to detect early signs of patient health deterioration and risk of falling

  February 11, 2019

   · 

  3 min read
• Pharm Country

  After, Inc. to showcase its latest predictive analytics solutions at the Field Service Medical Conference on February 25-27, 2019

  After, Inc., the leading provider of Warranty Analytics 2.0 Solutions, will introduce its Field Service Optimization Suite to the nation’s largest Medical Equipment & Device Manufacturers next week in San Diego, California

  February 11, 2019

   · 

  2 min read
• Deals

  VIASPACE Plans to Complete Acquisition of Elite Therapeutics

  VIASPACE, Inc. announced that it now plans to complete the acquisition of luxury cosmetics company Elite Therapeutics.

  February 11, 2019

   · 

  3 min read
• Algatech Delivers Potent Astaxanthin in Whole-food Format

  Taking the “whole food” approach Algatechnologies Ltd. (“Algatech”) presents AstaPure® Arava, its clean-label, all-natural whole-algae complex.

  February 11, 2019

   · 

  3 min read
• Pharm Country

  NanoViricides President Dr. Diwan to Present at the BIO CEO & Investor 2019 Event in New York City Tomorrow Feb 12th at 2:30pm

  NanoViricides, Inc., a company with a novel platform technology to treat difficult and life-threatening viral diseases, announces that its President Dr. Anil Diwan will present the Company at the BIO CEO & Investor Conference being held at the New York Marriott Marquis on Feb 11th and 12th, 2019.

  February 11, 2019

   · 

  8 min read
• Pharm Country

  Sanofi and Regeneron offer Praluent® (alirocumab) at a new reduced U.S. list price

  This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients

  February 11, 2019

   · 

  12 min read
• Pharm Country

  Soligenix Receives US Patent Expanding Protection for its Ricin Toxin Vaccine, RiVax®

  Soligenix, Inc. announced the allowance of a new United States patent protecting its ricin toxin vaccine, RiVax®.

  February 11, 2019

   · 

  9 min read
• BioForest

  CTI BioPharma Receives $10 Million Milestone Payment for TRISENOX®

  CTI BioPharma Corp. announced that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd.

  February 11, 2019

   · 

  2 min read
• Business

  Ocean Harvest Technology Ltd Achieves Positive Results for OceanFeed Poultry in Trials at the University of Guelph, and in Commercial Applications

  OceanFeed Poultry is a proprietary blend of red, brown, and green seaweeds containing unique polysaccharides and bioactives which is made by Ocean Harvest Technology Ltd.

  February 11, 2019

   · 

  2 min read
• Drug Development

  Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at 2019 AAD Annual Meeting

  Concert Pharmaceuticals, Inc. announced that interim clinical data from its CTP-543 Phase 2 trial in alopecia areata has been selected for an oral presentation at the Late-Breaking Research Program during the American Academy of Dermatology Annual Meeting being held March 1 - 5, 2019 in Washington, D.C.

  February 11, 2019

   · 

  4 min read